These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 24235815

  • 1. Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study.
    Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA.
    Drug Des Devel Ther; 2013; 7():1323-8. PubMed ID: 24235815
    [Abstract] [Full Text] [Related]

  • 2. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients.
    Doesch AO, Ammon K, Konstandin M, Celik S, Kristen A, Frankenstein L, Buss S, Hardt S, Sack FU, Katus HA, Dengler TJ.
    Transplantation; 2009 Sep 27; 88(6):835-41. PubMed ID: 19920784
    [Abstract] [Full Text] [Related]

  • 3. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
    Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO.
    Clin Res Cardiol; 2018 Feb 27; 107(2):138-147. PubMed ID: 29098378
    [Abstract] [Full Text] [Related]

  • 4. Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.
    Zhang R, Bobylev D, Stiefel P, Haverich A, Bara C.
    Clin Res Cardiol; 2012 Aug 27; 101(8):631-6. PubMed ID: 22391988
    [Abstract] [Full Text] [Related]

  • 5. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.
    Zhang R, Haverich A, Strüber M, Simon A, Pichlmaier M, Bara C.
    Clin Res Cardiol; 2008 Nov 27; 97(11):811-9. PubMed ID: 18648727
    [Abstract] [Full Text] [Related]

  • 6. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 7. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.
    Rivinius R, Helmschrott M, Rahm AK, Darche FF, Thomas D, Bruckner T, Doesch AO, Katus HA, Ehlermann P.
    Clin Res Cardiol; 2022 Feb 27; 111(2):141-153. PubMed ID: 32572551
    [Abstract] [Full Text] [Related]

  • 8. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C.
    Circulation; 2004 Apr 06; 109(13):1674-9. PubMed ID: 14981003
    [Abstract] [Full Text] [Related]

  • 9. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators.
    Lancet; 2008 Sep 06; 372(9641):807-16. PubMed ID: 18757088
    [Abstract] [Full Text] [Related]

  • 10. Ivabradine in patients with inappropriate sinus tachycardia.
    Zellerhoff S, Hinterseer M, Felix Krull B, Schulze-Bahr E, Fabritz L, Breithardt G, Kirchhof P, Kääb S.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec 06; 382(5-6):483-6. PubMed ID: 20859616
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
    Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP.
    J Am Coll Cardiol; 2012 Oct 09; 60(15):1323-9. PubMed ID: 22981555
    [Abstract] [Full Text] [Related]

  • 12. Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.
    Kim BH, Cho KI, Kim SM, Kim N, Han J, Kim JY, Kim IJ.
    Heart Vessels; 2013 Jul 09; 28(4):524-35. PubMed ID: 23142972
    [Abstract] [Full Text] [Related]

  • 13. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P.
    Arch Cardiovasc Dis; 2014 Jan 09; 107(1):33-41. PubMed ID: 24440004
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia.
    Calò L, Rebecchi M, Sette A, Martino A, de Ruvo E, Sciarra L, De Luca L, Zuccaro LM, Giunta G, Ciccaglioni A, Lioy E, Fedele F.
    Heart Rhythm; 2010 Sep 09; 7(9):1318-23. PubMed ID: 20621618
    [Abstract] [Full Text] [Related]

  • 15. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure.
    Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R.
    Am Heart J; 2013 Oct 09; 166(4):654-661.e6. PubMed ID: 24093844
    [Abstract] [Full Text] [Related]

  • 16. Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia: a long-term follow-up study.
    Martino A, Rebecchi M, Sette A, Cicogna F, Politano A, Sgueglia M, de Ruvo E, Volterrani M, Calo' L.
    J Cardiovasc Med (Hagerstown); 2021 Dec 01; 22(11):892-900. PubMed ID: 34747925
    [Abstract] [Full Text] [Related]

  • 17. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 18. Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine.
    Raja DC, Kapoor A, Sinha A, Kashyap S, Khanna R, Kumar S, Garg N, Tewari S, Goel P.
    Indian Heart J; 2018 Dec 01; 70(2):246-251. PubMed ID: 29716702
    [Abstract] [Full Text] [Related]

  • 19. Treatment of inappropriate sinus tachycardia with ivabradine.
    Annamaria M, Lupo PP, Foresti S, De Ambroggi G, de Ruvo E, Sciarra L, Cappato R, Calo L.
    J Interv Card Electrophysiol; 2016 Jun 01; 46(1):47-53. PubMed ID: 26467151
    [Abstract] [Full Text] [Related]

  • 20. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    Bonnet D, Berger F, Jokinen E, Kantor PF, Daubeney PEF.
    J Am Coll Cardiol; 2017 Sep 05; 70(10):1262-1272. PubMed ID: 28859790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.